Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated helminth mass drug administration with seasonal malaria chemoprevention in Ghanaian children
PACTR202312489417172Not yet recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sulfadoxine + pyrimethamine, amodiaquine, albendazole and praziquantel in malaria, Soil-Transmitted Helminthiases (STH) and schistosomiasis (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Change in haemoglobin concentration. Planned start May 2024; status: not yet recruiting.
02
Drugs
sulfadoxine + pyrimethamineamodiaquinealbendazolepraziquantel
03
Conditions
malariaSoil-Transmitted Helminthiases (STH)schistosomiasis
Beyond the preview
Go deeper on PACTR202312489417172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202312489417172.